Logos Global Management LP Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$757.6B
Holdings
46
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXOALX ONCOLOGY HLDGS INC | 3,136,981 | $118.4B | 15.63% | |
| 2 | KROSKEROS THERAPEUTICS INC | 1,600,000 | $61.7B | 8.15% | |
| 3 | NKTXNKARTA INC | 2,047,178 | $61.5B | 8.12% | |
| 4 | —FORMA THERAPEUTICS HLDGS INC | 1,173,188 | $58.5B | 7.72% | |
| 5 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 850,000 | $46.9B | 6.19% | |
| 6 | TGTXTG THERAPEUTICS INC | 1,750,000 | $46.8B | 6.18% | |
| 7 | SRPTSAREPTA THERAPEUTICS INC | 275,000 | $38.6B | 5.10% | |
| 8 | RPTXREPARE THERAPEUTICS INC | 976,894 | $30.1B | 3.97% | |
| 9 | BTAIEURBIOXCEL THERAPEUTICS INC | 550,000 | $23.8B | 3.15% | |
| 10 | RNAAVIDITY BIOSCIENCES INC | 721,454 | $20.3B | 2.68% | |
| 11 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,200,000 | $17.8B | 2.35% | |
| 12 | CMPSCOMPASS PATHWAYS PLC | 500,000 | $17.4B | 2.30% | |
| 13 | CYTKCYTOKINETICS INC | 750,000 | $16.2B | 2.14% | |
| 14 | DYNDYNE THERAPEUTICS INC | 800,000 | $16.2B | 2.13% | |
| 15 | SG7SAGE THERAPEUTICS INC | 250,000 | $15.3B | 2.02% | |
| 16 | —CALLIDITAS THERAPEUTICS AB | 550,000 | $13.2B | 1.74% | |
| 17 | BMY-RBRISTOL-MYERS SQUIBB CO | 5,500,000 | $12.4B | 1.63% | |
| 18 | —ATHIRA PHARMA INC | 610,000 | $11.3B | 1.49% | |
| 19 | KYMRKYMERA THERAPEUTICS INC | 300,920 | $9.7B | 1.28% | |
| 20 | NRIXNURIX THERAPEUTICS INC | 275,000 | $9.6B | 1.27% | |
| 21 | HRMYHARMONY BIOSCIENCES HLDGS IN | 275,000 | $9.3B | 1.23% | |
| 22 | 5E7ITEOS THERAPEUTICS INC | 300,000 | $7.4B | 0.98% | |
| 23 | —THERAPEUTICS ACQUISITION COR | 500,000 | $7.2B | 0.95% | |
| 24 | —AKOUOS INC | 310,000 | $7.1B | 0.94% | |
| 25 | —UNUM THERAPEUTICS INC | 2,700,000 | $6.3B | 0.83% | |
| 26 | INBXUSDINHIBRX INC | 311,578 | $5.6B | 0.74% | |
| 27 | —LIFESCI ACQUISITION CORP | 400,000 | $5.4B | 0.72% | |
| 28 | PMVPPMV PHARMACEUTICALS INC | 150,000 | $5.3B | 0.70% | |
| 29 | —PANDION THERAPEUTICS INC | 450,000 | $5.2B | 0.68% | |
| 30 | LRMRLARIMAR THERAPEUTICS INC | 330,000 | $5.0B | 0.66% | |
| 31 | OMGBPOUTSET MED INC | 100,000 | $5.0B | 0.66% | |
| 32 | ANNXANNEXON INC | 159,622 | $4.8B | 0.64% | |
| 33 | PASGPASSAGE BIO INC | 344,438 | $4.5B | 0.60% | |
| 34 | RLAYRELAY THERAPEUTICS INC | 100,000 | $4.3B | 0.56% | |
| 35 | KALVKALVISTA PHARMACEUTICALS INC | 300,000 | $3.8B | 0.50% | |
| 36 | BDTXBLACK DIAMOND THERAPEUTICS I | 123,465 | $3.7B | 0.49% | |
| 37 | NARIUSDINARI MED INC | 50,000 | $3.5B | 0.46% | |
| 38 | —HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.3B | 0.44% | |
| 39 | PLRXPLIANT THERAPEUTICS INC | 136,715 | $3.1B | 0.41% | |
| 40 | —PANACEA ACQUISITION CORP | 200,000 | $2.4B | 0.32% | |
| 41 | AFIBACUTUS MED INC | 75,000 | $2.2B | 0.30% | |
| 42 | —CHARDAN HEALTHCR ACQSTN 2 CO | 200,000 | $2.1B | 0.28% | |
| 43 | —BCTG ACQUISITION CORP | 200,000 | $2.1B | 0.27% | |
| 44 | —FS DEV CORP | 100,000 | $1.1B | 0.15% | |
| 45 | —ARYA SCIENCES ACQUISTION CO | 100,000 | $1.1B | 0.15% | |
| 46 | RAPTEURRAPT THERAPEUTICS INC | 31,100 | $1.0B | 0.13% |